{
    "nctId": "NCT02936947",
    "briefTitle": "Study to Evaluate the Benefit of a High Frequency Ventilation System During Lung or Breast Cancer Radiotherapy Treatment",
    "officialTitle": "Study to Evaluate the Benefit of a High Frequency Ventilation System During Lung or Breast Cancer Radiotherapy Treatment",
    "overallStatus": "TERMINATED",
    "conditions": "Lung Cancer, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 8,
    "primaryOutcomeMeasure": "HFPV vs free breathing: 1/3 decrease of V20 (lung) or 1/2 decrease of Dmax (breast)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast cancer eligible for tomotherapy or linear accelerator with ABC system\n* lung cancer eligible for curative tomotherapy and with a significant breathing movements amplitude\n* lung cancer eligible for ablative stereotaxis\n* WHO 0 or 1\n\nExclusion Criteria:\n\n* patients requiring oxygen or not able to lie on the back (dyspnea)\n* pulmonary functions altered\n* cardiac insufficiency\n* patient not able to breathe with the High Frequency Ventilation System\n* risk of pneumothorax when experiencing High Frequency Ventilation",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}